Spectrum Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Spectrum Pharmaceuticals

10/11/2022 22:03

* Spectrum Pharmaceuticals Inc  SPPI.OQ  reported a
quarterly
adjusted loss of 12 cents​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 15 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Spectrum Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 12 cents​.
    * The mean earnings estimate of analysts had risen by
about 5.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Spectrum Pharmaceuticals Inc shares had fallen by 5.3%
this
quarter and lost 67.9% so far this year.
    * The company reported a quarterly loss of $21.93 million.
    * Wall Street's median 12-month price target for Spectrum
Pharmaceuticals Inc is $3.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 10:03 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.15          -0.12          Beat
 Jun. 30 2022      -0.16          -0.17          Missed
 Mar. 31 2022      -0.19          -0.08          Beat
 Dec. 31 2021      -0.21          -0.26          Missed